Beam Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BEAM and other ETFs, options, and stocks.

About BEAM

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201.

CEO

John Evans

CEOJohn Evans

Employees

436

Employees436

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2017

Founded2017

Employees

436

Employees436

BEAM Key Statistics

Market cap

1.80B

Market cap1.80B

Price-Earnings ratio

-11.55

Price-Earnings ratio-11.55

Dividend yield

—

Dividend yield—

Average volume

1.82M

Average volume1.82M

High today

—

High today—

Low today

—

Low today—

Open price

$21.52

Open price$21.52

Volume

0.00

Volume0.00

52 Week high

$49.50

52 Week high$49.50

52 Week low

$16.95

52 Week low$16.95

Analyst ratings

53%

of 15 ratings

Buy

53.3%

Hold

46.7%

Sell